For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
AAN 2015 Coverage
The system is currently being assessed for its use in stroke rehabilition in the Phase 3 supplemental study 'E-FIT', involving 60 patients.
For patients with comorbid depression and TBI, NILT is effective in bringing remission.
Escitalopram may be better for the treatment of depression than tDCS.
Catastrophizing makes pain more painful, makes it last longer, and makes pain much harder to treat.
Putative pathogensis insights have grown tremendously in the past 10 years.
Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.